A pharmaceutical company required strategic U.S. market entry solutions for an older product, newly approved under FDA standards. Targeted toward the managed care and government segments, the product faced numerous challenges and controversy over revised FDA mandates, which resulted in new labeling and a higher price structure.

Learn how Quintiles helped the company achieve 90% national formulary coverage for this product.